share_log

赛生药业(06600)：9万份购股权已获行使

Saisheng Pharmaceutical (06600): 90,000 share options have been exercised

Zhitong Finance ·  May 7 22:32

Saisheng Pharmaceutical (06600) announced that on May 7, 2024, in accordance with the rules of the initial public offering after-sales share purchase option plan...

According to Zhitong Finance App News, Saisheng Pharmaceutical (06600) announced that on May 7, 2024, according to the rules of the initial public offering after-sales share option plan: 7,000 share options granted under the initial public offering after-sales share option plan have expired; and 90,000 share options granted under the initial public offering after-sales share option plan have been exercised.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment